chr5-13864620-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001369.3(DNAH5):​c.4373G>A​(p.Arg1458Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000594 in 1,614,026 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. R1458R) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0030 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00035 ( 4 hom. )

Consequence

DNAH5
NM_001369.3 missense

Scores

1
3
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.69
Variant links:
Genes affected
DNAH5 (HGNC:2950): (dynein axonemal heavy chain 5) This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008085579).
BP6
Variant 5-13864620-C-T is Benign according to our data. Variant chr5-13864620-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 238974.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-13864620-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00297 (452/152200) while in subpopulation AFR AF= 0.0101 (421/41512). AF 95% confidence interval is 0.00934. There are 2 homozygotes in gnomad4. There are 225 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DNAH5NM_001369.3 linkuse as main transcriptc.4373G>A p.Arg1458Gln missense_variant 28/79 ENST00000265104.5 NP_001360.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DNAH5ENST00000265104.5 linkuse as main transcriptc.4373G>A p.Arg1458Gln missense_variant 28/791 NM_001369.3 ENSP00000265104 P4
ENST00000503244.2 linkuse as main transcriptn.253+4065C>T intron_variant, non_coding_transcript_variant 4
DNAH5ENST00000681290.1 linkuse as main transcriptc.4328G>A p.Arg1443Gln missense_variant 28/79 ENSP00000505288 A1
ENST00000637153.1 linkuse as main transcriptn.213+4105C>T intron_variant, non_coding_transcript_variant 5

Frequencies

GnomAD3 genomes
AF:
0.00297
AC:
451
AN:
152082
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0101
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00432
GnomAD3 exomes
AF:
0.000812
AC:
204
AN:
251316
Hom.:
0
AF XY:
0.000736
AC XY:
100
AN XY:
135814
show subpopulations
Gnomad AFR exome
AF:
0.0101
Gnomad AMR exome
AF:
0.000636
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.0000980
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000968
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.000346
AC:
506
AN:
1461826
Hom.:
4
Cov.:
33
AF XY:
0.000325
AC XY:
236
AN XY:
727218
show subpopulations
Gnomad4 AFR exome
AF:
0.0100
Gnomad4 AMR exome
AF:
0.000514
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.0000696
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000648
Gnomad4 OTH exome
AF:
0.00106
GnomAD4 genome
AF:
0.00297
AC:
452
AN:
152200
Hom.:
2
Cov.:
33
AF XY:
0.00302
AC XY:
225
AN XY:
74400
show subpopulations
Gnomad4 AFR
AF:
0.0101
Gnomad4 AMR
AF:
0.00118
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00427
Alfa
AF:
0.000417
Hom.:
3
Bravo
AF:
0.00327
ESP6500AA
AF:
0.0118
AC:
52
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00104
AC:
126
Asia WGS
AF:
0.00173
AC:
6
AN:
3476
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000178

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:3
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
Likely benign, no assertion criteria providedclinical testingNatera, Inc.Feb 26, 2021- -
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 06, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Primary ciliary dyskinesia 3 Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.51
CADD
Uncertain
23
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.28
T
Eigen
Benign
0.14
Eigen_PC
Benign
0.18
FATHMM_MKL
Benign
0.59
D
LIST_S2
Uncertain
0.91
D
MetaRNN
Benign
0.0081
T
MetaSVM
Benign
-0.39
T
MutationAssessor
Benign
2.0
M
MutationTaster
Benign
0.66
D
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-1.7
N
REVEL
Benign
0.26
Sift
Uncertain
0.0030
D
Polyphen
0.41
B
Vest4
0.26
MVP
0.65
MPC
0.30
ClinPred
0.028
T
GERP RS
5.3
Varity_R
0.47
gMVP
0.44

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61747551; hg19: chr5-13864729; COSMIC: COSV54233756; API